Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01557-0002-0000-2 |
Chemical Name: | 6-Nitrobenzimidazole |
CASRN: | 94-52-0 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 753791_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Positive |
No Activation | 2 | Positive |
Induced Rat Liver S9 | 2_S9 | Positive |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 6-Nitrobenzimidazole | 500 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
650 | 100 | 4 | 0.040 | 4.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
750 | 100 | 8 | 0.080 | 8.0 | 0 | 0.000 | 0.0 | 8 | 0.080 | 8.0 | 0 | 0.000 | 0.0 | ||
850 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
1000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 50 | 31 | 0.620 | 36.0 | 13 | 0.260 | 20.0 | 18 | 0.360 | 28.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 14 | 0.560 | 44.0 | 4 | 0.160 | 16.0 | 10 | 0.400 | 36.0 | 0 | 0.000 | 0.0 | |
Trend: | 1.661 | -0.727 | 2.142 | ||||||||||||
Probability: | 0.048 | 0.766 | 0.016 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 6-Nitrobenzimidazole | 1250 | 25 | 26 | 1.040 | 60.0 | 8 | 0.320 | 24.0 | 18 | 0.720 | 60.0 | 0 | 0.000 | 0.0 |
1875 | 25 | 40 | 1.600 | 84.0 | 8 | 0.320 | 24.0 | 32 | 1.280 | 80.0 | 0 | 0.000 | 0.0 | ||
2500 | 25 | 61 | 2.440 | 100.0 | 15 | 0.600 | 36.0 | 46 | 1.840 | 100.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 100 | 23 | 0.230 | 19.0 | 5 | 0.050 | 5.0 | 18 | 0.180 | 14.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 28 | 1.120 | 60.0 | 11 | 0.440 | 36.0 | 17 | 0.680 | 44.0 | 0 | 0.000 | 0.0 | |
Trend: | 10.953 | 5.561 | 10.815 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 200 | 3 | 0.015 | 1.5 | 1 | 0.005 | 0.5 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 6-Nitrobenzimidazole | 250 | 200 | 16 | 0.080 | 6.0 | 0 | 0.000 | 0.0 | 16 | 0.080 | 6.0 | 0 | 0.000 | 0.0 |
500 | 200 | 11 | 0.055 | 5.0 | 1 | 0.005 | 0.5 | 10 | 0.050 | 4.5 | 0 | 0.000 | 0.0 | ||
750 | 100 | 25 | 0.250 | 15.0 | 0 | 0.000 | 0.0 | 15 | 0.150 | 14.0 | 10 | 0.100 | 1.0 | ||
1000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 50 | 26 | 0.520 | 36.0 | 14 | 0.280 | 22.0 | 12 | 0.240 | 18.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 100 | 10 | 0.100 | 10.0 | 1 | 0.010 | 1.0 | 9 | 0.090 | 9.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.767 | -0.269 | 3.711 | ||||||||||||
Probability: | 0.000 | 0.606 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 200 | 4 | 0.020 | 2.0 | 2 | 0.010 | 1.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 6-Nitrobenzimidazole | 1250 | 25 | 22 | 0.880 | 68.0 | 3 | 0.120 | 12.0 | 19 | 0.760 | 64.0 | 0 | 0.000 | 0.0 |
1875 | 10 | 15 | 1.500 | 100.0 | 1 | 0.100 | 10.0 | 14 | 1.400 | 100.0 | 0 | 0.000 | 0.0 | ||
2500 | 25 | 21 | 0.840 | 76.0 | 0 | 0.000 | 0.0 | 21 | 0.840 | 76.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 200 | 21 | 0.105 | 9.5 | 5 | 0.025 | 2.0 | 16 | 0.080 | 7.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 13 | 0.520 | 44.0 | 2 | 0.080 | 8.0 | 11 | 0.440 | 40.0 | 0 | 0.000 | 0.0 | |
Trend: | 11.838 | 1.015 | 12.191 | ||||||||||||
Probability: | 0.000 | 0.155 | 0.000 |